Project ALS is pleased to share that the FDA has approved the drug edaravone – the first approved ALS treatment in over 20 years.
Edaravone, a free radical scavenger, appears to react with nerve-damaging compounds generated as part of the disease process. After six months of treatment, on top of standard-of-care, data showed the intravenous drug reduced the rate of functional decline in patients by about a third.
Read more
Show Up for ALS
THEY SHOWED UP. WILL YOU? Watch the message.♥️ Support the mission. Fund the research. This ALS Awareness Month, familiar faces are coming together for one
May 29, 2026
No Comments
